Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,244,000 | 1,247,000 | 2,122,000 | 1,265,000 | 820,000 |
| Marketable Securities | 47,403,000 | 32,805,000 | 21,609,000 | 24,752,000 | 25,359,000 |
| Receivables | 10,446,000 | 9,596,000 | 8,958,000 | 9,901,000 | 10,245,000 |
| Inventories | 4,993,000 | 4,458,000 | 4,381,000 | 4,788,000 | 5,334,000 |
| Other current assets | 1,154,000 | 1,092,000 | 972,000 | 1,035,000 | 1,182,000 |
| TOTAL | $71,550,000 | $54,253,000 | $43,076,000 | $48,227,000 | $48,651,000 |
| Non-Current Assets | |||||
| PPE Net | 13,194,000 | 12,936,000 | 13,287,000 | 14,332,000 | 14,925,000 |
| Investments And Advances | 12,576,000 | 13,536,000 | 11,478,000 | 8,430,000 | 7,105,000 |
| Intangibles | 38,405,000 | 38,405,000 | 39,185,000 | 40,331,000 | 41,579,000 |
| Other Non-Current Assets | 3,614,000 | 3,802,000 | 4,122,000 | 3,929,000 | 4,255,000 |
| TOTAL | $67,789,000 | $68,679,000 | $68,072,000 | $67,022,000 | $67,864,000 |
| Total Assets | $139,339,000 | $122,932,000 | $111,148,000 | $115,249,000 | $116,515,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,645,000 | 7,613,000 | 9,320,000 | 9,193,000 | 9,448,000 |
| Accounts payable and accrued liabilities | 2,595,000 | 1,573,000 | 1,751,000 | 1,649,000 | 1,928,000 |
| Accrued Expenses | 1,549,000 | 1,565,000 | 1,667,000 | 1,752,000 | 1,640,000 |
| Other current liabilities | 12,632,000 | 12,046,000 | 11,456,000 | 8,173,000 | 7,100,000 |
| TOTAL | $26,109,000 | $23,340,000 | $27,009,000 | $21,503,000 | $23,193,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,864,000 | 21,064,000 | 7,963,000 | 7,152,000 | 7,246,000 |
| Other Non-Current Liabilities | 15,770,000 | 15,237,000 | 15,472,000 | 13,429,000 | 13,616,000 |
| TOTAL | $49,995,000 | $39,151,000 | $26,399,000 | $26,411,000 | $26,753,000 |
| Total Liabilities | $76,104,000 | $62,491,000 | $53,408,000 | $47,914,000 | $49,946,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,749,143 | 6,747,979 | 6,745,270 | 6,742,936 | 6,740,995 |
| Common Shares | 443,000 | 443,000 | 443,000 | 443,000 | 443,000 |
| Retained earnings | 51,965,000 | 51,863,000 | 49,142,000 | 53,175,000 | 50,912,000 |
| Other shareholders' equity | -2,123,000 | -4,703,000 | -4,737,000 | 944,000 | 2,603,000 |
| TOTAL | $63,235,000 | $60,441,000 | $57,740,000 | $67,335,000 | $66,569,000 |
| Total Liabilities And Equity | $139,339,000 | $122,932,000 | $111,148,000 | $115,249,000 | $116,515,000 |